Product NDC: | 55390-007 |
Proprietary Name: | Valproate Sodium |
Non Proprietary Name: | Valproate Sodium |
Active Ingredient(s): | 100 mg/mL & nbsp; Valproate Sodium |
Administration Route(s): | INTRAVENOUS |
Dosage Form(s): | INJECTION |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 55390-007 |
Labeler Name: | Bedford Laboratories |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA076295 |
Marketing Category: | ANDA |
Start Marketing Date: | 20031206 |
Package NDC: | 55390-007-10 |
Package Description: | 10 VIAL, SINGLE-DOSE in 1 BOX (55390-007-10) > 5 mL in 1 VIAL, SINGLE-DOSE |
NDC Code | 55390-007-10 |
Proprietary Name | Valproate Sodium |
Package Description | 10 VIAL, SINGLE-DOSE in 1 BOX (55390-007-10) > 5 mL in 1 VIAL, SINGLE-DOSE |
Product NDC | 55390-007 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Valproate Sodium |
Dosage Form Name | INJECTION |
Route Name | INTRAVENOUS |
Start Marketing Date | 20031206 |
Marketing Category Name | ANDA |
Labeler Name | Bedford Laboratories |
Substance Name | VALPROATE SODIUM |
Strength Number | 100 |
Strength Unit | mg/mL |
Pharmaceutical Classes | Anti-epileptic Agent [EPC],Decreased Central Nervous System Disorganized Electrical Activity [PE],Mood Stabilizer [EPC] |